Checkpoint Therapeutics - Stock Price History | CKPT

Historical daily share price chart and data for Checkpoint Therapeutics since 2021 adjusted for splits. The latest closing stock price for Checkpoint Therapeutics as of October 27, 2021 is 3.26.
  • The all-time high Checkpoint Therapeutics stock closing price was 10.00 on July 05, 2017.
  • The Checkpoint Therapeutics 52-week high stock price is 5.38, which is 65% above the current share price.
  • The Checkpoint Therapeutics 52-week low stock price is 2.16, which is 33.7% below the current share price.
  • The average Checkpoint Therapeutics stock price for the last 52 weeks is 2.95.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Checkpoint Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 2.1350 1.6900 4.2400 1.1100 2.6500 54.07%
2019 2.8760 2.1100 5.0000 1.1800 1.7200 -5.49%
2018 3.4103 3.8600 5.6000 1.5400 1.8200 -53.09%
2017 7.0306 10.0000 10.0000 3.4600 3.8800 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.264B $0.001B
Checkpoint Therapeutics, Inc. is a clinical stage, immuno oncology biopharmaceutical. It focused on the acquisition, development and commercialization of non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Checkpoint Therapeutics, Inc. is headquartered in New York City.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.416B 8.62
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.526B 21.21
Biohaven Pharmaceutical Holding (BHVN) United States $9.249B 0.00
Emergent Biosolutions (EBS) United States $2.705B 6.53
Arcus Biosciences (RCUS) United States $2.404B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.873B 0.00
Myovant Sciences (MYOV) United Kingdom $1.831B 0.00
Zymeworks (ZYME) Canada $1.080B 0.00
Ambrx Biopharma (AMAM) United States $0.464B 0.00
SQZ Biotechnologies (SQZ) United States $0.372B 0.00
Enzo Biochem (ENZ) United States $0.161B 15.86